Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05299515 · ClinicalTrials.gov registry record · NA
Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT05299515: Completed NA study, sponsored by University of Maryland, College Park.
NCT05299515 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05299515, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this Type 1 hybrid effectiveness-implementation randomized controlled trial (RCT), we will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over six months.
Primary Outcome
Defined dichotomously as retention (yes/no) in methadone treatment
Interventions
- BEHAVIORAL Peer-Delivered Behavioral Activation ("Peer Activate")
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2025-09-24 |
| Phase | NA |
What the finished NCT05299515 record still lists
NCT05299515 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Peer-Delivered Behavioral Activation ("Peer Activate") is the first listed.
NCT05299515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05299515 about?
NCT05299515 is a clinical study titled "Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence". The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland. The interven...
What is the current status of trial NCT05299515?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2022-04-05. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT05299515?
The interventions under investigation include: Peer-Delivered Behavioral Activation ("Peer Activate") (BEHAVIORAL).
Who is sponsoring clinical trial NCT05299515?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05299515's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI